We already knew that an oral version of Kevetrin was preferred and even necessary because of it's short half life.Current clinical trial is (although showing positive results) showing the need for more frequent dosing.
WE ALL F#Ck!n6 KNEW THAT so..SHUT the F#(k UP!!!...MFC
Kelt
(1)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links